Outcomes Intelligence Registry™
(Site-based, non-research, growth-focused)
Best for: Market adoption, physician engagement, and outcomes storytelling
Practice-embedded registry capturing patient-reported outcomes as part of routine care
No IRB oversight; operates as a commercial quality and insights program
Supports post-market surveillance, thought leadership, and field education
Flexible PRO sets aligned to commercial strategy
Real-time dashboards for internal teams and participating practices
What sponsors get:
Fast deployment, broad site participation, and longitudinal outcomes that support market growth and value narratives.
Evidence-Grade RWE Cohort™
(Patient-direct, no site workflow, minimal burden)
Best for: Early evidence, payer discussions, and publication-ready datasets
Prospective, observational cohort with IRB exemption
Direct-to-patient engagement (eConsent, SMS/email PRO collection)
No site staff burden; no site contracts required
Fixed, protocol-defined endpoints to protect downstream use
Designed to meet FDA and payer expectations for RWE
What sponsors get:
Clean, defensible real-world evidence—quickly—without the friction of traditional studies.
Traditional Prospective Study
(Site-based, IRB-approved clinical research)
Best for: Regulatory submissions, label expansion, and high-rigor endpoints
-
Full protocol development, IRB approval, and site activation
-
Site-collected clinical and patient-reported data
-
Structured monitoring, data management, and audit trails
-
Suitable for IDE support, PMA supplements, and high-impact publications
-
Conducted with Celéri’s pain-specialized investigator network
What sponsors get:
Gold-standard clinical evidence with the rigor required for regulatory and scientific scrutiny.
PainRWD™ Science Cloud
(Secondary data & advanced analytics layer)
Best for: Hypothesis generation, comparator insights, and economic modeling
Access to a large, de-identified real-world pain dataset
Longitudinal PROs, procedures, diagnoses, and utilization signals
Advanced analytics, subgroup analysis, and benchmarking
Supports HEOR, payer dossiers, and feasibility assessments
Can stand alone or enhance prospective and registry studies
What sponsors get:
Immediate insights at scale—without waiting for new data collection.
